Skip to main content

Clinical Trial Results


Dr. Matthew Budoff and Dr. C. Michael Gibson Discuss: STOP – Effect of Semaglutide on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: Final Results of the Stop Study

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab


Disclosures: TBA